Global Influenza Vaccines Market Analysis and Forecast 2022 April 2017

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022 report
provides that global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2022.
Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast
population base together with significantly low vaccination coverage in emerging markets, rising
government support for immunization and growing awareness of the value of influenza vaccine in
preventing disease are the prominent factors that will fuel the growth of the influenza vaccines
market.
Complete report on Telemedicine spread across 125 pages, profiling 10 companies and supported
with tables and figures; is Now Available @ http://www.reportsnreports.com/reports/Global-
Influenza-Vaccines-Market
Key Highlights of the Report:
Geographically, North America is the largest market for influenza vaccines capturing nearly 50%
market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third
largest market for influenza vaccines, followed by Latin America with around XX% share in 2016.
Australasia accounted for least share of the influenza vaccines market in 2016. On the basis of
country, United States captures majority of the influenza vaccines market share. Japan is the second
leading market for influenza vaccines with around XX% share. China and India are the third and
fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2016.
Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza
vaccines.
In the influenza vaccines brand sales segment, Sanofi’s Fluzone holds the maximum share of the
market being followed by Fluvirin/Flucelvax. GSK’s Fluarix/FluLaval accounts for the third highest
share of the influenza vaccines market. Afluria/Fluvax and FluMist/Fluenz stands at the fourth and
fifth position in the influenza vaccines market, while Flublok has captured least share of the
influenza vaccines market. This is the 3rd edition report on influenza vaccines market.The report
titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022”
provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 216 Page
report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market
landscape.
Enquire For Complete PDF Report@
http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=953510
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2022)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 -
2022)
3. Global - Influenza Vaccines Brand Sales and Forecast to 2022
4. Global Influenza Vaccines Market - Major Deals
5. Global Influenza Vaccines Market - Driving Factors and Challenges
Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region: